XML 25 R9.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities      
Net income $ 112,818 $ 154,783 $ 50,210
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation and amortization 10,283 5,040 3,702
Deferred income taxes 13,226 (41,247) 4,987
Stock-based compensation, net of amounts capitalized 47,834 31,442 7,252
Non-cash lease expense 2,027 1,159 2,433
Amortization of premium on marketable securities, net 3,115 4,332 197
Loss on sale of marketable securities 1,093 1,231 0
Amortization of deferred contract costs 8,785 9,755 6,883
Gain on sale of business 0 0 (4,698)
Other 1,454 410 403
Changes in operating assets and liabilities, net of effect of acquisition:      
Accounts receivable (26,242) (31,017) (20,452)
Prepaid expenses and other assets (3,448) (9,089) (1,833)
Deferred contract costs (8,462) (9,609) (9,384)
Accounts payable, accrued expenses and other liabilities (195) 8,664 7,285
Deferred revenue 17,527 1,828 38,571
Operating lease liabilities (213) (1,107) (2,583)
Net cash provided by operating activities 179,602 126,575 82,973
Cash flows from investing activities      
Cash paid for acquisition, net of cash acquired (53,500) 0 (31,682)
Purchases of property and equipment (1,701) (1,912) (245)
Internal-use software development costs (4,483) (3,785) (4,365)
Purchases of marketable securities (190,560) (1,317,193) (78,880)
Maturities of marketable securities 83,139 47,919 40,537
Sales of marketable securities 107,182 633,802 0
Proceeds from sale of business 0 0 4,230
Other 0 595 (12)
Net cash used in investing activities (59,923) (640,574) (70,417)
Cash flows from financing activities      
Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions 0 553,905 0
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants 9,926 12,612 8,897
Proceeds from issuance of common stock in connection with the employee stock purchase plan 4,759 1,395 0
Taxes paid related to net share settlement of equity awards (3,822) (817) 0
Repurchase of common stock (85,324) (2,698) (2,022)
Payments of deferred offering costs 0 (3,982) (1,468)
Net cash provided by (used in) financing activities (74,461) 560,415 5,407
Net increase in cash and cash equivalents 45,218 46,416 17,963
Cash and cash equivalents, beginning of period 112,809 66,393 48,430
Cash and cash equivalents, end of period 158,027 112,809 66,393
Supplemental disclosures of cash flow information      
Cash paid for taxes 5,231 206 5,972
Non-cash financing and investing activities      
Conversion of redeemable convertible preferred stock to common stock 0 81,458 0
Unpaid deferred offering costs 0 0 782
Common stock issued in acquisition 0 0 1,062
Capitalized stock-based compensation for internal-use software development costs 865 497 195
Amounts held in escrow related to sale of business 0 0 470
Fair value of contingent earn-out consideration included in purchase consideration 21,134 0 0
Operating lease right-of-use assets obtained in exchange for operating lease liabilities 14,759 1,151 0
Repurchase included in accrued expenses $ 748 $ 0 $ 0